Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,508 | -16,517 | 11,133 | -7,732 | -3,085 |
| Depreciation Amortization | 30 | 87 | 58 | 77 | 17 |
| Accounts receivable | -2,346 | 140 | 128 | 191 | -177 |
| Other Working Capital | -3,085 | 2,148 | 1,092 | 1,057 | 1,033 |
| Other Operating Activity | 2,881 | 1,644 | -21,115 | 625 | 305 |
| Operating Cash Flow | $-7,028 | $-12,498 | $-8,704 | $-5,782 | $-1,907 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,000 | -28,000 | -28,025 | -28,025 | -13,000 |
| PPE Investments | -115 | -500 | -246 | -149 | -86 |
| Purchase Of Investment | -700 | -72,518 | -65,913 | -46,762 | -20,039 |
| Sale Of Investment | 21,149 | 22,502 | 18,053 | 6,028 | 1,943 |
| Investing Cash Flow | $7,334 | $-78,516 | $-76,131 | $-68,908 | $-31,182 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 66,831 | 66,708 | 66,647 | 259 |
| Other Financing Activity | -8 | -30 | -23 | -16 | -9 |
| Financing Cash Flow | $-8 | $66,801 | $66,685 | $66,631 | $250 |
| Exchange Rate Effect | 9 | N/A | N/A | 7 | -6 |
| Beginning Cash Position | 18,795 | 43,008 | 43,008 | 43,008 | 43,008 |
| End Cash Position | 19,102 | 18,795 | 24,858 | 34,956 | 10,163 |
| Net Cash Flow | $307 | $-24,213 | $-18,150 | $-8,052 | $-32,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,028 | -12,498 | -8,704 | -5,782 | -1,907 |
| Capital Expenditure | -115 | -500 | -246 | -149 | -86 |
| Free Cash Flow | -7,143 | -12,998 | -8,950 | -5,931 | -1,993 |